title: Thymopentin (TP 5) in the management of patients with uremia.
authors.affiliation: Chair of Hematology, Institute of Clinical Medicine, Institute of Clinical Medicine, University of Palermo, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Bonaccorso
authors.forename: V
authors.initials: V
authors.lastname: Gebbia
authors.forename: M
authors.initials: M
authors.lastname: Tambone Reyes
authors.forename: M S
authors.initials: MS
authors.lastname: Pappalardo
authors.forename: S
authors.initials: S
authors.lastname: Peralta
authors.forename: M
authors.initials: M
authors.lastname: La Iuppa
authors.forename: M
authors.initials: M
authors.lastname: Teresi
authors.forename: P
authors.initials: P
authors.lastname: Di Marco
authors.forename: P
authors.initials: P
authors.lastname: Citarrella
authors.forename: S
authors.initials: S
authors.lastname: Mansueto
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D007958:Leukocyte Count; D012016:Reference Values; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D016305:Thymopentin / Q000627:therapeutic use*; D014511:Uremia / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D016305:Thymopentin